BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19933969)

  • 1. The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
    Singer DE; Fang MC; Go AS
    Arch Intern Med; 2009 Nov; 169(21):2032; author reply 2033. PubMed ID: 19933969
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation: a pathway to clinical effectiveness.
    Barnes GD; Froehlich JB
    Am J Med; 2009 Feb; 122(2):126-8. PubMed ID: 19185085
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.
    Uchiyama S
    Intern Med; 2001 Dec; 40(12):1166-7. PubMed ID: 11813834
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

  • 6. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 9. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 10. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustainability and impact of warfarin compliance for atrial fibrillation.
    Kuo S; Burrill J
    Med Health R I; 2007 Dec; 90(12):378-80. PubMed ID: 18314828
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial fibrillation and stroke prevention.
    Hart RG
    N Engl J Med; 2003 Sep; 349(11):1015-6. PubMed ID: 12968083
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 14. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral anticoagulant therapy for patients with atrial fibrillation--an update.
    Hylek EM
    Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran: safer, more effective and easier to use than warfarin.
    Cardiovasc J Afr; 2009; 20(5):311-2. PubMed ID: 19907807
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.
    Palagummi P; Saltzman H; Ezekowitz M
    Am Heart J; 2005 Jan; 149(1 Suppl):S32-5. PubMed ID: 15644791
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral anticoagulation and stroke in atrial fibrillation.
    Epstein EF; Natarajan I
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674042
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral anticoagulation and stroke in atrial fibrillation.
    Boos CJ
    N Engl J Med; 2003 Dec; 349(24):2360-1; author reply 2360-1. PubMed ID: 14674043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.